Resolved

ABILIFY MAINTENA

OTSUKA PHARMACEUTICAL CO LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ABILIFY MAINTENA in Canada?

Not currently. The most recent shortage report for ABILIFY MAINTENA 400MG is marked resolved (last updated June 27, 2026).

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength400MG

Last updated2026-06-27

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02420872

Strength

400MG

Dosage Form

KIT POWDER FOR SUSPENSION, SUSTAINED-RELEASE

Route

INTRAMUSCULAR

Active Ingredient

ARIPIPRAZOLE

Tier

Unrated

Last Updated

2026-06-27

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from OTSUKA PHARMACEUTICAL CO LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

5MG · DIN 02322382

10MG · DIN 02322390

15MG · DIN 02322404

20MG · DIN 02322412

30MG · DIN 02322455

2MG · DIN 02322374